A new challenge of unfractionated heparin anticoagulation treatment for moderate to severe COVID-19 in Japan
Hypercoagulation and anticoagulation treatment have become new challenges in coronavirus disease 2019 (COVID-19) patients during the COVID-19 pandemic. We herein suggest an algorithm for an anticoagulation treatment with unfractionated heparin in moderate to severe COVID-19 cases in Japan, and repor...
Gespeichert in:
| Veröffentlicht in: | Global Health & Medicine 2020/06/30, Vol.2(3), pp.190-192 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 192 |
|---|---|
| container_issue | 3 |
| container_start_page | 190 |
| container_title | Global Health & Medicine |
| container_volume | 2 |
| creator | Sato, Rubuna Ishikane, Masahiro Kinoshita, Noriko Suzuki, Tetsuya Nakamoto, Takato Hayakawa, Kayoko Bekki, Norifumi Hara, Hisao Ohmagari, Norio |
| description | Hypercoagulation and anticoagulation treatment have become new challenges in coronavirus disease 2019 (COVID-19) patients during the COVID-19 pandemic. We herein suggest an algorithm for an anticoagulation treatment with unfractionated heparin in moderate to severe COVID-19 cases in Japan, and report a case of COVID-19 pneumonia with anticoagulation treatment. Although several promising drugs for COVID-19 are being tested in clinical trials, definitive treatments have not yet been established. In this report, we demaonstrate that anticoagulation treatment with unfractionated heparin has the possibility of becoming at least a supportive treatment for COVID-19 patients. |
| doi_str_mv | 10.35772/ghm.2020.01044 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7731183</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2470902670</sourcerecordid><originalsourceid>FETCH-LOGICAL-c573t-781cd74d108c307f2d3743a98ea73065fd469a8bc22cf013c8e7ce29848fa5663</originalsourceid><addsrcrecordid>eNpVkU1v1DAQhiMEolXpmRvykUu244_EzgWpbGkpqtQLcLWmziSbKrEXxyni3-N2SwBLli3NM--M9BTFWw4bWWktzvrdtBEgYAMclHpRHAslVdnwRr1c_6Y-Kk7n-R4ARMUFSHhdHMl8wEB9XIznzNNP5nY4juR7YqFji-8iujQEj4latqM9xsEz9GlwAftlxMcaS5EwTeQT60JkU2gpZp6lwGZ6oEhse_v9-qLkDcvNX3CP_k3xqsNxptPn96T4dvnp6_ZzeXN7db09vyldpWUqteGu1arlYJwE3YlWaiWxMYRaQl11raobNHdOCNcBl86QdiQao0yHVV3Lk-LDIXe_3E3UurxjxNHu4zBh_GUDDvb_ih92tg8PVmvJuZE54P1zQAw_FpqTnYbZ0Tiip7DMVigNDYhaQ0bPDqiLYZ4jdesYDvZJk82a7KMm-6Qpd7z7d7uV_yMlAx8PwP2csKcVwJgFjHTIszLfv6lrMZuMlrz8DdYdpoE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2470902670</pqid></control><display><type>article</type><title>A new challenge of unfractionated heparin anticoagulation treatment for moderate to severe COVID-19 in Japan</title><source>J-STAGE Free</source><source>PubMed Central</source><creator>Sato, Rubuna ; Ishikane, Masahiro ; Kinoshita, Noriko ; Suzuki, Tetsuya ; Nakamoto, Takato ; Hayakawa, Kayoko ; Bekki, Norifumi ; Hara, Hisao ; Ohmagari, Norio</creator><creatorcontrib>Sato, Rubuna ; Ishikane, Masahiro ; Kinoshita, Noriko ; Suzuki, Tetsuya ; Nakamoto, Takato ; Hayakawa, Kayoko ; Bekki, Norifumi ; Hara, Hisao ; Ohmagari, Norio</creatorcontrib><description>Hypercoagulation and anticoagulation treatment have become new challenges in coronavirus disease 2019 (COVID-19) patients during the COVID-19 pandemic. We herein suggest an algorithm for an anticoagulation treatment with unfractionated heparin in moderate to severe COVID-19 cases in Japan, and report a case of COVID-19 pneumonia with anticoagulation treatment. Although several promising drugs for COVID-19 are being tested in clinical trials, definitive treatments have not yet been established. In this report, we demaonstrate that anticoagulation treatment with unfractionated heparin has the possibility of becoming at least a supportive treatment for COVID-19 patients.</description><identifier>ISSN: 2434-9186</identifier><identifier>EISSN: 2434-9194</identifier><identifier>DOI: 10.35772/ghm.2020.01044</identifier><identifier>PMID: 33330806</identifier><language>eng</language><publisher>Japan: National Center for Global Health and Medicine</publisher><subject>anticoagulation treatment ; Communication ; COVID-19 ; hypercoagulation ; unfractionated heparin</subject><ispartof>Global Health & Medicine, 2020/06/30, Vol.2(3), pp.190-192</ispartof><rights>2020 National Center for Global Health and Medicine</rights><rights>2020, National Center for Global Health and Medicine.</rights><rights>2020, National Center for Global Health and Medicine 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c573t-781cd74d108c307f2d3743a98ea73065fd469a8bc22cf013c8e7ce29848fa5663</citedby><cites>FETCH-LOGICAL-c573t-781cd74d108c307f2d3743a98ea73065fd469a8bc22cf013c8e7ce29848fa5663</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731183/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731183/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,1877,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33330806$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sato, Rubuna</creatorcontrib><creatorcontrib>Ishikane, Masahiro</creatorcontrib><creatorcontrib>Kinoshita, Noriko</creatorcontrib><creatorcontrib>Suzuki, Tetsuya</creatorcontrib><creatorcontrib>Nakamoto, Takato</creatorcontrib><creatorcontrib>Hayakawa, Kayoko</creatorcontrib><creatorcontrib>Bekki, Norifumi</creatorcontrib><creatorcontrib>Hara, Hisao</creatorcontrib><creatorcontrib>Ohmagari, Norio</creatorcontrib><title>A new challenge of unfractionated heparin anticoagulation treatment for moderate to severe COVID-19 in Japan</title><title>Global Health & Medicine</title><addtitle>GHM</addtitle><description>Hypercoagulation and anticoagulation treatment have become new challenges in coronavirus disease 2019 (COVID-19) patients during the COVID-19 pandemic. We herein suggest an algorithm for an anticoagulation treatment with unfractionated heparin in moderate to severe COVID-19 cases in Japan, and report a case of COVID-19 pneumonia with anticoagulation treatment. Although several promising drugs for COVID-19 are being tested in clinical trials, definitive treatments have not yet been established. In this report, we demaonstrate that anticoagulation treatment with unfractionated heparin has the possibility of becoming at least a supportive treatment for COVID-19 patients.</description><subject>anticoagulation treatment</subject><subject>Communication</subject><subject>COVID-19</subject><subject>hypercoagulation</subject><subject>unfractionated heparin</subject><issn>2434-9186</issn><issn>2434-9194</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpVkU1v1DAQhiMEolXpmRvykUu244_EzgWpbGkpqtQLcLWmziSbKrEXxyni3-N2SwBLli3NM--M9BTFWw4bWWktzvrdtBEgYAMclHpRHAslVdnwRr1c_6Y-Kk7n-R4ARMUFSHhdHMl8wEB9XIznzNNP5nY4juR7YqFji-8iujQEj4latqM9xsEz9GlwAftlxMcaS5EwTeQT60JkU2gpZp6lwGZ6oEhse_v9-qLkDcvNX3CP_k3xqsNxptPn96T4dvnp6_ZzeXN7db09vyldpWUqteGu1arlYJwE3YlWaiWxMYRaQl11raobNHdOCNcBl86QdiQao0yHVV3Lk-LDIXe_3E3UurxjxNHu4zBh_GUDDvb_ih92tg8PVmvJuZE54P1zQAw_FpqTnYbZ0Tiip7DMVigNDYhaQ0bPDqiLYZ4jdesYDvZJk82a7KMm-6Qpd7z7d7uV_yMlAx8PwP2csKcVwJgFjHTIszLfv6lrMZuMlrz8DdYdpoE</recordid><startdate>20200630</startdate><enddate>20200630</enddate><creator>Sato, Rubuna</creator><creator>Ishikane, Masahiro</creator><creator>Kinoshita, Noriko</creator><creator>Suzuki, Tetsuya</creator><creator>Nakamoto, Takato</creator><creator>Hayakawa, Kayoko</creator><creator>Bekki, Norifumi</creator><creator>Hara, Hisao</creator><creator>Ohmagari, Norio</creator><general>National Center for Global Health and Medicine</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200630</creationdate><title>A new challenge of unfractionated heparin anticoagulation treatment for moderate to severe COVID-19 in Japan</title><author>Sato, Rubuna ; Ishikane, Masahiro ; Kinoshita, Noriko ; Suzuki, Tetsuya ; Nakamoto, Takato ; Hayakawa, Kayoko ; Bekki, Norifumi ; Hara, Hisao ; Ohmagari, Norio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c573t-781cd74d108c307f2d3743a98ea73065fd469a8bc22cf013c8e7ce29848fa5663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>anticoagulation treatment</topic><topic>Communication</topic><topic>COVID-19</topic><topic>hypercoagulation</topic><topic>unfractionated heparin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sato, Rubuna</creatorcontrib><creatorcontrib>Ishikane, Masahiro</creatorcontrib><creatorcontrib>Kinoshita, Noriko</creatorcontrib><creatorcontrib>Suzuki, Tetsuya</creatorcontrib><creatorcontrib>Nakamoto, Takato</creatorcontrib><creatorcontrib>Hayakawa, Kayoko</creatorcontrib><creatorcontrib>Bekki, Norifumi</creatorcontrib><creatorcontrib>Hara, Hisao</creatorcontrib><creatorcontrib>Ohmagari, Norio</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Global Health & Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sato, Rubuna</au><au>Ishikane, Masahiro</au><au>Kinoshita, Noriko</au><au>Suzuki, Tetsuya</au><au>Nakamoto, Takato</au><au>Hayakawa, Kayoko</au><au>Bekki, Norifumi</au><au>Hara, Hisao</au><au>Ohmagari, Norio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A new challenge of unfractionated heparin anticoagulation treatment for moderate to severe COVID-19 in Japan</atitle><jtitle>Global Health & Medicine</jtitle><addtitle>GHM</addtitle><date>2020-06-30</date><risdate>2020</risdate><volume>2</volume><issue>3</issue><spage>190</spage><epage>192</epage><pages>190-192</pages><issn>2434-9186</issn><eissn>2434-9194</eissn><abstract>Hypercoagulation and anticoagulation treatment have become new challenges in coronavirus disease 2019 (COVID-19) patients during the COVID-19 pandemic. We herein suggest an algorithm for an anticoagulation treatment with unfractionated heparin in moderate to severe COVID-19 cases in Japan, and report a case of COVID-19 pneumonia with anticoagulation treatment. Although several promising drugs for COVID-19 are being tested in clinical trials, definitive treatments have not yet been established. In this report, we demaonstrate that anticoagulation treatment with unfractionated heparin has the possibility of becoming at least a supportive treatment for COVID-19 patients.</abstract><cop>Japan</cop><pub>National Center for Global Health and Medicine</pub><pmid>33330806</pmid><doi>10.35772/ghm.2020.01044</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2434-9186 |
| ispartof | Global Health & Medicine, 2020/06/30, Vol.2(3), pp.190-192 |
| issn | 2434-9186 2434-9194 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7731183 |
| source | J-STAGE Free; PubMed Central |
| subjects | anticoagulation treatment Communication COVID-19 hypercoagulation unfractionated heparin |
| title | A new challenge of unfractionated heparin anticoagulation treatment for moderate to severe COVID-19 in Japan |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T00%3A31%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20new%20challenge%20of%20unfractionated%20heparin%20anticoagulation%20treatment%20for%20moderate%20to%20severe%20COVID-19%20in%20Japan&rft.jtitle=Global%20Health%20&%20Medicine&rft.au=Sato,%20Rubuna&rft.date=2020-06-30&rft.volume=2&rft.issue=3&rft.spage=190&rft.epage=192&rft.pages=190-192&rft.issn=2434-9186&rft.eissn=2434-9194&rft_id=info:doi/10.35772/ghm.2020.01044&rft_dat=%3Cproquest_pubme%3E2470902670%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2470902670&rft_id=info:pmid/33330806&rfr_iscdi=true |